NIDAN — Nidan Laboratories and Healthcare Cashflow Statement
0.000.00%
- IN₹258.54m
- IN₹350.65m
- IN₹245.28m
- 75
- 83
- 16
- 63
Annual cashflow statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 33 | 45.2 | 48.1 | -23.7 | 27.6 |
Depreciation | |||||
Non-Cash Items | 33.6 | 19 | 19.5 | 63.3 | -1.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -55.1 | -12.3 | 40.3 | -13 | -27.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 43.5 | 78.3 | 139 | 55.2 | 22.8 |
Capital Expenditures | -32.2 | -70.7 | -6.68 | -7.36 | -9.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -287 | -23.2 | -98.7 | 7.21 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -32.2 | -357 | -29.9 | -106 | -2.19 |
Financing Cash Flow Items | -33.6 | -24.4 | -22.2 | -19.7 | -18.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -12.2 | 287 | -106 | -4.87 | -30.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.964 | 8.05 | 3.18 | -55.7 | -9.51 |